反应详情

The title compound was prepared from 4-(2,4-dioxo-thiazolidin-5-ylmethyl)-N-[4-(4-oxo-piperidine-1-yl)-phenyl]-benzenesulfonamide (which was obtained in Example 231) and (S)-4-[2-hydroxy-3-aminopropoxy]-1,3-dihydro-2H-benzimidazol-2-one (U.S. Pat. No. 5,786,356/1998) according to the procedure of Example 278 as an off-white solid; 1H NMR (300 MHz, DMSO-d6) δ 1.40-1.60 (m, 2H), 1.90-2.10 (m, 2H), 2.50-2.70 (m, 2H), 2.70-3.50 (m, 5H), 3.60 (brd, J=11.6 Hz, 2H), 4.00 (brs, 3H), 4.60 (dd, J=9.4, 4.2 Hz, 1H), 6.58 (d, J=7.8 Hz, 1H), 6.62 (d, J=8.1 Hz, 1H), 6.70-6.90 (m, 5H), 7.35 (d, J=8.4 Hz, 2H), 7.55 (d, J 8.4 Hz, 2H), 9.70 (brs, 1H), 10.61 (brs, 1H), 10.72 (brs, 1H); MS (ES) m/z: 667.0 (MH+); HRMS Calcd. for C31H35N6O7S2 (MH+): 677.2009. Found: 677.1999.